Lai Xiuhua, Zhang Jiapeng, Chen Jing, Lai Cuiwei, Huang Chunping
Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, Guangdong, P. R. China.
Medical College of Jiaying University, Meizhou, Guangdong, P. R. China.
J Int Med Res. 2020 Oct;48(10):300060520948337. doi: 10.1177/0300060520948337.
Stress urinary incontinence (SUI) is prevalent worldwide, particularly among elderly women. Although electroacupuncture (EA) has been accepted by many patients and physicians in Asia, its efficacy for SUI has not been evaluated scientifically and systematically. We aimed to conduct a systematic evaluation of the efficacy and safety of EA treatment for women with SUI.
We retrieved publications up to February 2019 from seven databases. Randomized controlled trials for women with SUI treated by EA were included. Therapeutic effect, 1-hour urine leakage and International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) scores were the primary outcomes. The Cochrane Collection's RevMan 5.3 software was used to pool data.
The 15 included articles demonstrated that EA for SUI was effective (odds ratio [OR], confidence interval [CI] = 5.64, 4.19-7.59; Ι = 22%). ICIQ-SF scores increased (standard mean difference, CI = -0.48, -0.62 to -0.33; Ι = 32%) and 1-hour urine leakage decreased (OR, CI = -4.14, -4.96 to -3.33; Ι = 78%) in patients undergoing EA compared with those receiving sham EA, physical exercise or medication.
EA for women with SUI exhibited significant efficacy and safety for key outcomes.
压力性尿失禁（SUI）在全球普遍存在，尤其是老年女性。尽管电针（EA）在亚洲已被许多患者和医生所接受，但其治疗SUI的疗效尚未得到科学系统的评估。我们旨在对电针治疗女性SUI的疗效和安全性进行系统评价。
检索截至2019年2月的7个数据库中的文献。纳入电针治疗女性SUI的随机对照试验。主要结局指标为治疗效果、1小时漏尿量和国际尿失禁咨询委员会简表（ICIQ-SF）评分。采用Cochrane协作网的RevMan 5.3软件进行数据合并。
纳入的15篇文章表明，电针治疗SUI有效（优势比[OR]，置信区间[CI]=5.64，4.19 - 7.59；I=22%）。与接受假电针、体育锻炼或药物治疗的患者相比，接受电针治疗的患者ICIQ-SF评分升高（标准均数差，CI=-0.48，-0.62至-0.33；I=32%），1小时漏尿量减少（OR，CI=-4.14，-4.96至-3.33；I=78%）。
电针治疗女性SUI在关键结局指标上显示出显著的疗效和安全性。
